Clinical Trial Update: BMI-Driven Tolerability and Efficacy of Entresto in Heart Failure Patients

View source ↗

Summary

This clinical trial is evaluating the tolerability and efficacy of Entresto (sacubitril/valsartan) in patients with heart failure and obesity, and is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Obesity

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: Lithuanian University of Health Sciences | Conditions: Heart Failure, Obesity | Status: RECRUITING